State Key Laboratory of Virology, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Nature. 2024 Nov;635(8040):978-986. doi: 10.1038/s41586-024-08121-5. Epub 2024 Oct 30.
Although coronaviruses use diverse receptors, the characterization of coronaviruses with unknown receptors has been impeded by a lack of infection models. Here we introduce a strategy to engineer functional customized viral receptors (CVRs). The modular design relies on building artificial receptor scaffolds comprising various modules and generating specific virus-binding domains. We identify key factors for CVRs to functionally mimic native receptors by facilitating spike proteolytic cleavage, membrane fusion, pseudovirus entry and propagation for various coronaviruses. We delineate functional SARS-CoV-2 spike receptor-binding sites for CVR design and reveal the mechanism of cell entry promoted by the N-terminal domain-targeting S2L20-CVR. We generated CVR-expressing cells for 12 representative coronaviruses from 6 subgenera, most of which lack known receptors, and show that a pan-sarbecovirus CVR supports propagation of a propagation-competent HKU3 pseudovirus and of authentic RsHuB2019A. Using an HKU5-specific CVR, we successfully rescued wild-type and ZsGreen-HiBiT-incorporated HKU5-1 (LMH03f) and isolated a HKU5 strain from bat samples. Our study demonstrates the potential of the CVR strategy for establishing native receptor-independent infection models, providing a tool for studying viruses that lack known susceptible target cells.
虽然冠状病毒使用多种受体,但由于缺乏感染模型,对于未知受体的冠状病毒的特征描述一直受到阻碍。在这里,我们介绍了一种工程功能性定制病毒受体(CVR)的策略。该模块化设计依赖于构建包含各种模块的人工受体支架,并生成特定的病毒结合结构域。我们确定了 CVR 功能模拟天然受体的关键因素,包括促进刺突蛋白的蛋白水解切割、膜融合、假病毒进入和各种冠状病毒的复制。我们为 CVR 设计划定了功能性 SARS-CoV-2 刺突受体结合位点,并揭示了靶向 N 端结构域的 S2L20-CVR 促进细胞进入的机制。我们为 6 个亚属的 12 种代表性冠状病毒生成了表达 CVR 的细胞,其中大多数缺乏已知的受体,并且表明一种泛 SARS-CoV 病毒的 CVR 支持具有复制能力的 HKU3 假病毒和真实的 RsHuB2019A 的复制。使用一种 HKU5 特异性 CVR,我们成功拯救了野生型和 ZsGreen-HiBiT 掺入的 HKU5-1(LMH03f),并从蝙蝠样本中分离出一株 HKU5 毒株。我们的研究证明了 CVR 策略在建立非天然受体依赖性感染模型方面的潜力,为研究缺乏已知易感靶细胞的病毒提供了一种工具。